nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CCR5—asthma	0.495	1	CbGaD
Maraviroc—CYP3A4—Fluticasone furoate—asthma	0.0213	0.0796	CbGbCtD
Maraviroc—CYP3A4—Budesonide—asthma	0.019	0.0709	CbGbCtD
Maraviroc—CYP3A4—Indacaterol—asthma	0.0174	0.0649	CbGbCtD
Maraviroc—CYP3A4—Ciclesonide—asthma	0.0174	0.0649	CbGbCtD
Maraviroc—CYP3A4—Salmeterol—asthma	0.0161	0.0603	CbGbCtD
Maraviroc—CYP3A4—Flunisolide—asthma	0.0161	0.0603	CbGbCtD
Maraviroc—CYP3A4—Salbutamol—asthma	0.0161	0.0603	CbGbCtD
Maraviroc—CYP3A4—Zileuton—asthma	0.0144	0.0538	CbGbCtD
Maraviroc—CYP3A4—Ipratropium bromide—asthma	0.0144	0.0538	CbGbCtD
Maraviroc—CYP3A4—Fluticasone Propionate—asthma	0.0137	0.0513	CbGbCtD
Maraviroc—CYP3A4—Zafirlukast—asthma	0.0127	0.0473	CbGbCtD
Maraviroc—CYP3A4—Tiotropium—asthma	0.0109	0.0407	CbGbCtD
Maraviroc—CYP3A4—Aminophylline—asthma	0.0104	0.0389	CbGbCtD
Maraviroc—CYP3A4—Theophylline—asthma	0.00978	0.0365	CbGbCtD
Maraviroc—CYP3A4—Montelukast—asthma	0.00927	0.0346	CbGbCtD
Maraviroc—CYP3A4—Loratadine—asthma	0.00927	0.0346	CbGbCtD
Maraviroc—CYP3A4—Methylprednisolone—asthma	0.00848	0.0317	CbGbCtD
Maraviroc—CYP3A4—Triamcinolone—asthma	0.00643	0.024	CbGbCtD
Maraviroc—CYP3A4—Betamethasone—asthma	0.00551	0.0206	CbGbCtD
Maraviroc—CYP3A4—Prednisolone—asthma	0.00544	0.0203	CbGbCtD
Maraviroc—CYP3A4—Hydrocortisone—asthma	0.00516	0.0193	CbGbCtD
Maraviroc—CYP3A4—Prednisone—asthma	0.00514	0.0192	CbGbCtD
Maraviroc—CCR5—respiratory system—asthma	0.00404	0.435	CbGeAlD
Maraviroc—CYP3A4—Dexamethasone—asthma	0.00321	0.012	CbGbCtD
Maraviroc—CCR5—cardiovascular system—asthma	0.00309	0.334	CbGeAlD
Maraviroc—CCR5—lung—asthma	0.00214	0.231	CbGeAlD
Maraviroc—CCR5—Signaling by GPCR—HRH4—asthma	0.000135	0.00144	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—NPSR1—asthma	0.000135	0.00144	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PMCH—asthma	0.000135	0.00144	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CCL2—asthma	0.000133	0.00142	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CSF2RB—asthma	0.000132	0.00141	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—EDN1—asthma	0.000131	0.00139	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—BDKRB2—asthma	0.00013	0.00138	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CCL5—asthma	0.00013	0.00138	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—TACR2—asthma	0.000129	0.00138	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCR8—asthma	0.000129	0.00138	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCL17—asthma	0.000127	0.00135	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PDE4A—asthma	0.000125	0.00133	CbGpPWpGaD
Maraviroc—CYP3A4—Estrogen metabolism—NQO1—asthma	0.000124	0.00132	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—KNG1—asthma	0.000118	0.00126	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—AGTR1—asthma	0.000118	0.00125	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CYSLTR1—asthma	0.000117	0.00124	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—POMC—asthma	0.000115	0.00122	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CXCL10—asthma	0.000115	0.00122	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—C3—asthma	0.000114	0.00122	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PDE4A—asthma	0.000113	0.00121	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—VIP—asthma	0.000113	0.0012	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—UTS2—asthma	0.000113	0.0012	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—C5AR1—asthma	0.000113	0.0012	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—ADRB2—asthma	0.000112	0.00119	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CCR4—asthma	0.000108	0.00115	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—IL6—asthma	0.000108	0.00115	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CYSLTR1—asthma	0.000106	0.00113	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CXCL8—asthma	0.000105	0.00112	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—IL2RB—asthma	0.000104	0.00111	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PDE4D—asthma	0.000103	0.0011	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—VIP—asthma	0.000102	0.00109	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—C5AR1—asthma	0.000102	0.00109	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—UTS2—asthma	0.000102	0.00109	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCL11—asthma	0.000102	0.00109	CbGpPWpGaD
Maraviroc—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—asthma	0.000102	0.00109	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—C3AR1—asthma	0.000101	0.00107	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—FCER2—asthma	0.000101	0.00107	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—C5—asthma	0.0001	0.00107	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PDE4B—asthma	0.0001	0.00107	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—TACR1—asthma	0.0001	0.00107	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—EDN1—asthma	9.97e-05	0.00106	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CCL5—asthma	9.89e-05	0.00105	CbGpPWpGaD
Maraviroc—CCR5—HIV Infection—CD4—asthma	9.89e-05	0.00105	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—HNMT—asthma	9.88e-05	0.00105	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCR4—asthma	9.81e-05	0.00104	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CYSLTR2—asthma	9.72e-05	0.00103	CbGpPWpGaD
Maraviroc—CYP3A4—Estrogen metabolism—GSTM1—asthma	9.47e-05	0.00101	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL2RB—asthma	9.45e-05	0.00101	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL22—asthma	9.38e-05	0.000999	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—LTB4R—asthma	9.38e-05	0.000999	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PTGDR—asthma	9.38e-05	0.000999	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PDE4D—asthma	9.36e-05	0.000997	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CCR3—asthma	9.19e-05	0.000978	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—POMC—asthma	9.14e-05	0.000974	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PDE4B—asthma	9.12e-05	0.000971	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—C5—asthma	9.12e-05	0.000971	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—TACR1—asthma	9.12e-05	0.000971	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—NPY—asthma	8.96e-05	0.000953	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CCL2—asthma	8.95e-05	0.000953	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CXCL8—asthma	8.9e-05	0.000947	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—C3—asthma	8.71e-05	0.000927	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—AGTR2—asthma	8.64e-05	0.00092	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCR3—asthma	8.34e-05	0.000888	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—EDNRB—asthma	8.27e-05	0.000881	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—NPS—asthma	8.19e-05	0.000872	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—TAC1—asthma	8.19e-05	0.000872	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—NPY—asthma	8.13e-05	0.000866	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CXCR3—asthma	8.03e-05	0.000855	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PMCH—asthma	7.98e-05	0.00085	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NPSR1—asthma	7.98e-05	0.00085	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HRH4—asthma	7.98e-05	0.00085	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PTGDR2—asthma	7.98e-05	0.00085	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—AGTR2—asthma	7.85e-05	0.000835	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CSF2RB—asthma	7.81e-05	0.000831	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCR8—asthma	7.65e-05	0.000814	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TACR2—asthma	7.65e-05	0.000814	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—IL5—asthma	7.61e-05	0.000811	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—EDNRB—asthma	7.51e-05	0.0008	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL17—asthma	7.5e-05	0.000799	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—TAC1—asthma	7.44e-05	0.000792	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—NPS—asthma	7.44e-05	0.000792	CbGpPWpGaD
Maraviroc—CYP3A4—Tryptophan metabolism—ALDH2—asthma	7.38e-05	0.000786	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—BDKRB2—asthma	7.35e-05	0.000782	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CXCR3—asthma	7.29e-05	0.000777	CbGpPWpGaD
Maraviroc—CCR5—Disease—DCN—asthma	7.24e-05	0.00077	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—ADCY2—asthma	7.11e-05	0.000757	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—IL3—asthma	7.08e-05	0.000754	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	7.07e-05	0.000753	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—POMC—asthma	6.96e-05	0.000741	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL5—asthma	6.91e-05	0.000736	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CCL2—asthma	6.81e-05	0.000725	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—KIF3A—asthma	6.69e-05	0.000712	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PDE4A—asthma	6.69e-05	0.000712	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—KNG1—asthma	6.68e-05	0.000712	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—BDKRB2—asthma	6.67e-05	0.00071	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—AGTR1—asthma	6.64e-05	0.000707	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CXCL10—asthma	6.49e-05	0.000691	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—ADCY2—asthma	6.46e-05	0.000687	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL3—asthma	6.43e-05	0.000685	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—ADRB2—asthma	6.3e-05	0.000671	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CYSLTR1—asthma	6.26e-05	0.000667	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—KNG1—asthma	6.07e-05	0.000646	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—C5AR1—asthma	6.05e-05	0.000644	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CMA1—asthma	6.05e-05	0.000644	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—UTS2—asthma	6.05e-05	0.000644	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—VIP—asthma	6.05e-05	0.000644	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL11—asthma	6.05e-05	0.000644	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—AGTR1—asthma	6.03e-05	0.000642	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—ITPR1—asthma	5.96e-05	0.000635	CbGpPWpGaD
Maraviroc—CCR5—Disease—CYBA—asthma	5.96e-05	0.000634	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CXCL10—asthma	5.9e-05	0.000628	CbGpPWpGaD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—asthma	5.85e-05	0.000623	CbGpPWpGaD
Maraviroc—CCR5—Disease—PARP1—asthma	5.83e-05	0.000621	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCR4—asthma	5.8e-05	0.000617	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—ADRB2—asthma	5.72e-05	0.000609	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—STAT6—asthma	5.69e-05	0.000605	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—EDN1—asthma	5.63e-05	0.0006	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CCL5—asthma	5.59e-05	0.000595	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL2RB—asthma	5.58e-05	0.000594	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PDE4D—asthma	5.53e-05	0.000589	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CSF2—asthma	5.51e-05	0.000586	CbGpPWpGaD
Maraviroc—CCR5—Disease—NOS1—asthma	5.48e-05	0.000584	CbGpPWpGaD
Maraviroc—CCR5—Disease—ADCY2—asthma	5.45e-05	0.00058	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—ITPR1—asthma	5.41e-05	0.000576	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—C5—asthma	5.39e-05	0.000574	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PDE4B—asthma	5.39e-05	0.000574	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TACR1—asthma	5.39e-05	0.000574	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CXCL8—asthma	5.39e-05	0.000573	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—EDN1—asthma	5.11e-05	0.000545	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCL5—asthma	5.08e-05	0.00054	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PLA2G4A—asthma	5.06e-05	0.000538	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CSF2—asthma	5e-05	0.000532	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—IL2RA—asthma	4.96e-05	0.000528	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCR3—asthma	4.93e-05	0.000525	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—C3—asthma	4.92e-05	0.000524	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—asthma	4.84e-05	0.000515	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NPY—asthma	4.8e-05	0.000511	CbGpPWpGaD
Maraviroc—CYP3A4—Tryptophan metabolism—CAT—asthma	4.73e-05	0.000504	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PPP2CA—asthma	4.66e-05	0.000496	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—AGTR2—asthma	4.63e-05	0.000493	CbGpPWpGaD
Maraviroc—CCR5—Disease—ITPR1—asthma	4.57e-05	0.000486	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL2RA—asthma	4.51e-05	0.00048	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—C3—asthma	4.47e-05	0.000476	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—EDNRB—asthma	4.44e-05	0.000473	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NPS—asthma	4.39e-05	0.000468	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TAC1—asthma	4.39e-05	0.000468	CbGpPWpGaD
Maraviroc—CCR5—Disease—CD86—asthma	4.35e-05	0.000463	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CXCR3—asthma	4.31e-05	0.000459	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CYBA—asthma	4.17e-05	0.000444	CbGpPWpGaD
Maraviroc—CCR5—Disease—SMAD3—asthma	4.11e-05	0.000437	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PARP1—asthma	4.08e-05	0.000435	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL5—asthma	4.08e-05	0.000435	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—BDKRB2—asthma	3.94e-05	0.00042	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—POMC—asthma	3.94e-05	0.000419	CbGpPWpGaD
Maraviroc—CCR5—Disease—PPP2CA—asthma	3.93e-05	0.000418	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ADCY2—asthma	3.81e-05	0.000406	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL3—asthma	3.8e-05	0.000405	CbGpPWpGaD
Maraviroc—CCR5—Disease—PDGFB—asthma	3.67e-05	0.000391	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—KNG1—asthma	3.59e-05	0.000382	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—POMC—asthma	3.57e-05	0.00038	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—AGTR1—asthma	3.56e-05	0.000379	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCL2—asthma	3.5e-05	0.000372	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL6R—asthma	3.49e-05	0.000371	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CXCL10—asthma	3.48e-05	0.000371	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—RHOA—asthma	3.47e-05	0.000369	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NTRK1—asthma	3.42e-05	0.000364	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ADRB2—asthma	3.38e-05	0.00036	CbGpPWpGaD
Maraviroc—CCR5—Disease—NOS2—asthma	3.27e-05	0.000348	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ITPR1—asthma	3.2e-05	0.00034	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—RHOA—asthma	3.15e-05	0.000335	CbGpPWpGaD
Maraviroc—Diarrhoea—Salbutamol—asthma	3.13e-05	0.000233	CcSEcCtD
Maraviroc—Vomiting—Formoterol—asthma	3.08e-05	0.000229	CcSEcCtD
Maraviroc—Vomiting—Arformoterol—asthma	3.08e-05	0.000229	CcSEcCtD
Maraviroc—Angiopathy—Methylprednisolone—asthma	3.08e-05	0.000229	CcSEcCtD
Maraviroc—Hallucination—Betamethasone—asthma	3.07e-05	0.000228	CcSEcCtD
Maraviroc—Hallucination—Dexamethasone—asthma	3.07e-05	0.000228	CcSEcCtD
Maraviroc—Nausea—Mometasone—asthma	3.07e-05	0.000228	CcSEcCtD
Maraviroc—Rash—Formoterol—asthma	3.06e-05	0.000227	CcSEcCtD
Maraviroc—Rash—Arformoterol—asthma	3.06e-05	0.000227	CcSEcCtD
Maraviroc—Mediastinal disorder—Methylprednisolone—asthma	3.06e-05	0.000227	CcSEcCtD
Maraviroc—Dermatitis—Arformoterol—asthma	3.05e-05	0.000227	CcSEcCtD
Maraviroc—Dermatitis—Formoterol—asthma	3.05e-05	0.000227	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CD86—asthma	3.05e-05	0.000324	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CXCL8—asthma	3.04e-05	0.000324	CbGpPWpGaD
Maraviroc—Headache—Formoterol—asthma	3.04e-05	0.000226	CcSEcCtD
Maraviroc—Headache—Arformoterol—asthma	3.04e-05	0.000226	CcSEcCtD
Maraviroc—Diarrhoea—Budesonide—asthma	3.03e-05	0.000226	CcSEcCtD
Maraviroc—Dizziness—Salbutamol—asthma	3.03e-05	0.000225	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—EDN1—asthma	3.02e-05	0.000322	CbGpPWpGaD
Maraviroc—Vomiting—Montelukast—asthma	3.02e-05	0.000224	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CCL5—asthma	3e-05	0.000319	CbGpPWpGaD
Maraviroc—Rash—Montelukast—asthma	2.99e-05	0.000223	CcSEcCtD
Maraviroc—Dermatitis—Montelukast—asthma	2.99e-05	0.000222	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PLA2G4A—asthma	2.99e-05	0.000318	CbGpPWpGaD
Maraviroc—Depression—Prednisone—asthma	2.98e-05	0.000222	CcSEcCtD
Maraviroc—Headache—Montelukast—asthma	2.97e-05	0.000221	CcSEcCtD
Maraviroc—Mental disorder—Methylprednisolone—asthma	2.97e-05	0.000221	CcSEcCtD
Maraviroc—Erythema—Triamcinolone—asthma	2.96e-05	0.00022	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CSF2—asthma	2.95e-05	0.000314	CbGpPWpGaD
Maraviroc—Malnutrition—Methylprednisolone—asthma	2.95e-05	0.000219	CcSEcCtD
Maraviroc—Erythema—Methylprednisolone—asthma	2.95e-05	0.000219	CcSEcCtD
Maraviroc—Acute coronary syndrome—Prednisone—asthma	2.95e-05	0.000219	CcSEcCtD
Maraviroc—CCR5—Disease—IL6R—asthma	2.94e-05	0.000313	CbGpPWpGaD
Maraviroc—Neuropathy peripheral—Prednisone—asthma	2.93e-05	0.000218	CcSEcCtD
Maraviroc—Myocardial infarction—Prednisone—asthma	2.93e-05	0.000218	CcSEcCtD
Maraviroc—Dizziness—Budesonide—asthma	2.93e-05	0.000218	CcSEcCtD
Maraviroc—Vomiting—Salbutamol—asthma	2.91e-05	0.000216	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—IL2—asthma	2.91e-05	0.00031	CbGpPWpGaD
Maraviroc—Rash—Salbutamol—asthma	2.89e-05	0.000215	CcSEcCtD
Maraviroc—Syncope—Prednisolone—asthma	2.88e-05	0.000214	CcSEcCtD
Maraviroc—Dermatitis—Salbutamol—asthma	2.88e-05	0.000214	CcSEcCtD
Maraviroc—Eye disorder—Betamethasone—asthma	2.88e-05	0.000214	CcSEcCtD
Maraviroc—Eye disorder—Dexamethasone—asthma	2.88e-05	0.000214	CcSEcCtD
Maraviroc—Nausea—Formoterol—asthma	2.88e-05	0.000214	CcSEcCtD
Maraviroc—Nausea—Arformoterol—asthma	2.88e-05	0.000214	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—SMAD3—asthma	2.87e-05	0.000306	CbGpPWpGaD
Maraviroc—Headache—Salbutamol—asthma	2.87e-05	0.000213	CcSEcCtD
Maraviroc—Loss of consciousness—Prednisolone—asthma	2.83e-05	0.00021	CcSEcCtD
Maraviroc—Nausea—Montelukast—asthma	2.82e-05	0.00021	CcSEcCtD
Maraviroc—Vomiting—Budesonide—asthma	2.82e-05	0.00021	CcSEcCtD
Maraviroc—Syncope—Hydrocortisone—asthma	2.82e-05	0.000209	CcSEcCtD
Maraviroc—Angiopathy—Betamethasone—asthma	2.8e-05	0.000208	CcSEcCtD
Maraviroc—Angiopathy—Dexamethasone—asthma	2.8e-05	0.000208	CcSEcCtD
Maraviroc—Rash—Budesonide—asthma	2.79e-05	0.000208	CcSEcCtD
Maraviroc—Dermatitis—Budesonide—asthma	2.79e-05	0.000208	CcSEcCtD
Maraviroc—Convulsion—Prednisolone—asthma	2.79e-05	0.000207	CcSEcCtD
Maraviroc—Headache—Budesonide—asthma	2.78e-05	0.000207	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—CXCL8—asthma	2.76e-05	0.000294	CbGpPWpGaD
Maraviroc—Loss of consciousness—Hydrocortisone—asthma	2.76e-05	0.000205	CcSEcCtD
Maraviroc—CCR5—Disease—SERPINE1—asthma	2.75e-05	0.000293	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PPP2CA—asthma	2.75e-05	0.000293	CbGpPWpGaD
Maraviroc—Alopecia—Dexamethasone—asthma	2.72e-05	0.000203	CcSEcCtD
Maraviroc—Alopecia—Betamethasone—asthma	2.72e-05	0.000203	CcSEcCtD
Maraviroc—Convulsion—Hydrocortisone—asthma	2.72e-05	0.000202	CcSEcCtD
Maraviroc—Nausea—Salbutamol—asthma	2.72e-05	0.000202	CcSEcCtD
Maraviroc—Discomfort—Prednisolone—asthma	2.71e-05	0.000201	CcSEcCtD
Maraviroc—Erythema—Betamethasone—asthma	2.68e-05	0.0002	CcSEcCtD
Maraviroc—Erythema—Dexamethasone—asthma	2.68e-05	0.0002	CcSEcCtD
Maraviroc—Myalgia—Hydrocortisone—asthma	2.67e-05	0.000199	CcSEcCtD
Maraviroc—Hallucination—Prednisone—asthma	2.67e-05	0.000199	CcSEcCtD
Maraviroc—Anxiety—Hydrocortisone—asthma	2.66e-05	0.000198	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—IL2RA—asthma	2.66e-05	0.000283	CbGpPWpGaD
Maraviroc—CCR5—Disease—RHOA—asthma	2.66e-05	0.000283	CbGpPWpGaD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	2.66e-05	0.000197	CcSEcCtD
Maraviroc—Syncope—Triamcinolone—asthma	2.65e-05	0.000197	CcSEcCtD
Maraviroc—Syncope—Methylprednisolone—asthma	2.65e-05	0.000197	CcSEcCtD
Maraviroc—Discomfort—Hydrocortisone—asthma	2.64e-05	0.000196	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—IL2—asthma	2.64e-05	0.000281	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—C3—asthma	2.64e-05	0.000281	CbGpPWpGaD
Maraviroc—Connective tissue disorder—Prednisone—asthma	2.64e-05	0.000196	CcSEcCtD
Maraviroc—Nausea—Budesonide—asthma	2.63e-05	0.000196	CcSEcCtD
Maraviroc—CCR5—Disease—NOS3—asthma	2.63e-05	0.00028	CbGpPWpGaD
Maraviroc—Oedema—Prednisolone—asthma	2.62e-05	0.000195	CcSEcCtD
Maraviroc—Loss of consciousness—Triamcinolone—asthma	2.6e-05	0.000193	CcSEcCtD
Maraviroc—Loss of consciousness—Methylprednisolone—asthma	2.59e-05	0.000193	CcSEcCtD
Maraviroc—Shock—Prednisolone—asthma	2.58e-05	0.000192	CcSEcCtD
Maraviroc—Cough—Triamcinolone—asthma	2.58e-05	0.000192	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—ALDH2—asthma	2.57e-05	0.000274	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PDGFB—asthma	2.57e-05	0.000274	CbGpPWpGaD
Maraviroc—Oedema—Hydrocortisone—asthma	2.56e-05	0.000191	CcSEcCtD
Maraviroc—Convulsion—Triamcinolone—asthma	2.56e-05	0.000191	CcSEcCtD
Maraviroc—Convulsion—Methylprednisolone—asthma	2.56e-05	0.00019	CcSEcCtD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—asthma	2.56e-05	0.000272	CbGpPWpGaD
Maraviroc—Infection—Hydrocortisone—asthma	2.55e-05	0.000189	CcSEcCtD
Maraviroc—Shock—Hydrocortisone—asthma	2.52e-05	0.000188	CcSEcCtD
Maraviroc—Myalgia—Triamcinolone—asthma	2.52e-05	0.000187	CcSEcCtD
Maraviroc—Nervous system disorder—Hydrocortisone—asthma	2.51e-05	0.000187	CcSEcCtD
Maraviroc—Myalgia—Methylprednisolone—asthma	2.51e-05	0.000187	CcSEcCtD
Maraviroc—Eye disorder—Prednisone—asthma	2.51e-05	0.000187	CcSEcCtD
Maraviroc—Anxiety—Methylprednisolone—asthma	2.5e-05	0.000186	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	2.49e-05	0.000186	CcSEcCtD
Maraviroc—Skin disorder—Hydrocortisone—asthma	2.49e-05	0.000185	CcSEcCtD
Maraviroc—Discomfort—Triamcinolone—asthma	2.49e-05	0.000185	CcSEcCtD
Maraviroc—Discomfort—Methylprednisolone—asthma	2.48e-05	0.000185	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—LEP—asthma	2.46e-05	0.000262	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—GSTT1—asthma	2.44e-05	0.00026	CbGpPWpGaD
Maraviroc—Anorexia—Hydrocortisone—asthma	2.44e-05	0.000182	CcSEcCtD
Maraviroc—Angiopathy—Prednisone—asthma	2.44e-05	0.000181	CcSEcCtD
Maraviroc—CCR5—Disease—CD4—asthma	2.42e-05	0.000258	CbGpPWpGaD
Maraviroc—Oedema—Triamcinolone—asthma	2.41e-05	0.00018	CcSEcCtD
Maraviroc—Syncope—Dexamethasone—asthma	2.41e-05	0.000179	CcSEcCtD
Maraviroc—Syncope—Betamethasone—asthma	2.41e-05	0.000179	CcSEcCtD
Maraviroc—CCR5—Disease—PTGS2—asthma	2.4e-05	0.000256	CbGpPWpGaD
Maraviroc—Infection—Triamcinolone—asthma	2.4e-05	0.000178	CcSEcCtD
Maraviroc—Infection—Methylprednisolone—asthma	2.39e-05	0.000178	CcSEcCtD
Maraviroc—Shock—Triamcinolone—asthma	2.37e-05	0.000177	CcSEcCtD
Maraviroc—Insomnia—Prednisolone—asthma	2.37e-05	0.000177	CcSEcCtD
Maraviroc—Alopecia—Prednisone—asthma	2.37e-05	0.000176	CcSEcCtD
Maraviroc—Shock—Methylprednisolone—asthma	2.37e-05	0.000176	CcSEcCtD
Maraviroc—Nervous system disorder—Methylprednisolone—asthma	2.36e-05	0.000176	CcSEcCtD
Maraviroc—Loss of consciousness—Dexamethasone—asthma	2.36e-05	0.000175	CcSEcCtD
Maraviroc—Loss of consciousness—Betamethasone—asthma	2.36e-05	0.000175	CcSEcCtD
Maraviroc—Paraesthesia—Prednisolone—asthma	2.36e-05	0.000175	CcSEcCtD
Maraviroc—Mental disorder—Prednisone—asthma	2.35e-05	0.000175	CcSEcCtD
Maraviroc—Skin disorder—Methylprednisolone—asthma	2.34e-05	0.000174	CcSEcCtD
Maraviroc—Malnutrition—Prednisone—asthma	2.34e-05	0.000174	CcSEcCtD
Maraviroc—Erythema—Prednisone—asthma	2.34e-05	0.000174	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Hydrocortisone—asthma	2.34e-05	0.000174	CcSEcCtD
Maraviroc—Convulsion—Betamethasone—asthma	2.33e-05	0.000173	CcSEcCtD
Maraviroc—Convulsion—Dexamethasone—asthma	2.33e-05	0.000173	CcSEcCtD
Maraviroc—Insomnia—Hydrocortisone—asthma	2.32e-05	0.000172	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—FN1—asthma	2.32e-05	0.000247	CbGpPWpGaD
Maraviroc—Paraesthesia—Hydrocortisone—asthma	2.3e-05	0.000171	CcSEcCtD
Maraviroc—Myalgia—Betamethasone—asthma	2.28e-05	0.00017	CcSEcCtD
Maraviroc—Myalgia—Dexamethasone—asthma	2.28e-05	0.00017	CcSEcCtD
Maraviroc—Anxiety—Betamethasone—asthma	2.28e-05	0.000169	CcSEcCtD
Maraviroc—Anxiety—Dexamethasone—asthma	2.28e-05	0.000169	CcSEcCtD
Maraviroc—Discomfort—Dexamethasone—asthma	2.26e-05	0.000168	CcSEcCtD
Maraviroc—Discomfort—Betamethasone—asthma	2.26e-05	0.000168	CcSEcCtD
Maraviroc—Pain—Prednisolone—asthma	2.24e-05	0.000167	CcSEcCtD
Maraviroc—Decreased appetite—Hydrocortisone—asthma	2.23e-05	0.000166	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Hydrocortisone—asthma	2.21e-05	0.000165	CcSEcCtD
Maraviroc—Fatigue—Hydrocortisone—asthma	2.21e-05	0.000164	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Triamcinolone—asthma	2.2e-05	0.000164	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Methylprednisolone—asthma	2.19e-05	0.000163	CcSEcCtD
Maraviroc—Pain—Hydrocortisone—asthma	2.19e-05	0.000163	CcSEcCtD
Maraviroc—Oedema—Dexamethasone—asthma	2.19e-05	0.000163	CcSEcCtD
Maraviroc—Oedema—Betamethasone—asthma	2.19e-05	0.000163	CcSEcCtD
Maraviroc—Insomnia—Triamcinolone—asthma	2.18e-05	0.000162	CcSEcCtD
Maraviroc—Insomnia—Methylprednisolone—asthma	2.18e-05	0.000162	CcSEcCtD
Maraviroc—Infection—Dexamethasone—asthma	2.18e-05	0.000162	CcSEcCtD
Maraviroc—Infection—Betamethasone—asthma	2.18e-05	0.000162	CcSEcCtD
Maraviroc—Paraesthesia—Triamcinolone—asthma	2.17e-05	0.000161	CcSEcCtD
Maraviroc—Paraesthesia—Methylprednisolone—asthma	2.16e-05	0.000161	CcSEcCtD
Maraviroc—Anaemia—Prednisone—asthma	2.16e-05	0.000161	CcSEcCtD
Maraviroc—Shock—Betamethasone—asthma	2.15e-05	0.00016	CcSEcCtD
Maraviroc—Shock—Dexamethasone—asthma	2.15e-05	0.00016	CcSEcCtD
Maraviroc—Nervous system disorder—Betamethasone—asthma	2.15e-05	0.00016	CcSEcCtD
Maraviroc—Nervous system disorder—Dexamethasone—asthma	2.15e-05	0.00016	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—POMC—asthma	2.11e-05	0.000225	CbGpPWpGaD
Maraviroc—CCR5—Disease—PTEN—asthma	2.1e-05	0.000223	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Hydrocortisone—asthma	2.1e-05	0.000156	CcSEcCtD
Maraviroc—Syncope—Prednisone—asthma	2.1e-05	0.000156	CcSEcCtD
Maraviroc—Anorexia—Betamethasone—asthma	2.09e-05	0.000155	CcSEcCtD
Maraviroc—Anorexia—Dexamethasone—asthma	2.09e-05	0.000155	CcSEcCtD
Maraviroc—Fatigue—Triamcinolone—asthma	2.08e-05	0.000155	CcSEcCtD
Maraviroc—Fatigue—Methylprednisolone—asthma	2.08e-05	0.000154	CcSEcCtD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—POMC—asthma	2.07e-05	0.000221	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL2—asthma	2.07e-05	0.00022	CbGpPWpGaD
Maraviroc—Pain—Triamcinolone—asthma	2.06e-05	0.000154	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—IL6R—asthma	2.06e-05	0.000219	CbGpPWpGaD
Maraviroc—Loss of consciousness—Prednisone—asthma	2.05e-05	0.000153	CcSEcCtD
Maraviroc—Body temperature increased—Hydrocortisone—asthma	2.03e-05	0.000151	CcSEcCtD
Maraviroc—Abdominal pain—Hydrocortisone—asthma	2.03e-05	0.000151	CcSEcCtD
Maraviroc—Convulsion—Prednisone—asthma	2.02e-05	0.000151	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—EGFR—asthma	2.02e-05	0.000215	CbGpPWpGaD
Maraviroc—Musculoskeletal discomfort—Dexamethasone—asthma	2e-05	0.000148	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Betamethasone—asthma	2e-05	0.000148	CcSEcCtD
Maraviroc—Myalgia—Prednisone—asthma	1.99e-05	0.000148	CcSEcCtD
Maraviroc—Anxiety—Prednisone—asthma	1.98e-05	0.000147	CcSEcCtD
Maraviroc—Insomnia—Dexamethasone—asthma	1.98e-05	0.000147	CcSEcCtD
Maraviroc—Insomnia—Betamethasone—asthma	1.98e-05	0.000147	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	1.98e-05	0.000147	CcSEcCtD
Maraviroc—Gastrointestinal pain—Methylprednisolone—asthma	1.97e-05	0.000146	CcSEcCtD
Maraviroc—Paraesthesia—Dexamethasone—asthma	1.97e-05	0.000146	CcSEcCtD
Maraviroc—Paraesthesia—Betamethasone—asthma	1.97e-05	0.000146	CcSEcCtD
Maraviroc—Discomfort—Prednisone—asthma	1.97e-05	0.000146	CcSEcCtD
Maraviroc—Hypersensitivity—Prednisolone—asthma	1.93e-05	0.000144	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—SERPINE1—asthma	1.93e-05	0.000205	CbGpPWpGaD
Maraviroc—Body temperature increased—Triamcinolone—asthma	1.91e-05	0.000142	CcSEcCtD
Maraviroc—Oedema—Prednisone—asthma	1.91e-05	0.000142	CcSEcCtD
Maraviroc—Abdominal pain—Methylprednisolone—asthma	1.9e-05	0.000142	CcSEcCtD
Maraviroc—Decreased appetite—Dexamethasone—asthma	1.9e-05	0.000142	CcSEcCtD
Maraviroc—Decreased appetite—Betamethasone—asthma	1.9e-05	0.000142	CcSEcCtD
Maraviroc—Infection—Prednisone—asthma	1.89e-05	0.000141	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Dexamethasone—asthma	1.89e-05	0.000141	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Betamethasone—asthma	1.89e-05	0.000141	CcSEcCtD
Maraviroc—Hypersensitivity—Hydrocortisone—asthma	1.89e-05	0.00014	CcSEcCtD
Maraviroc—Fatigue—Dexamethasone—asthma	1.89e-05	0.00014	CcSEcCtD
Maraviroc—Fatigue—Betamethasone—asthma	1.89e-05	0.00014	CcSEcCtD
Maraviroc—Shock—Prednisone—asthma	1.88e-05	0.00014	CcSEcCtD
Maraviroc—CCR5—Disease—STAT3—asthma	1.88e-05	0.0002	CbGpPWpGaD
Maraviroc—Pain—Dexamethasone—asthma	1.87e-05	0.000139	CcSEcCtD
Maraviroc—Pain—Betamethasone—asthma	1.87e-05	0.000139	CcSEcCtD
Maraviroc—Nervous system disorder—Prednisone—asthma	1.87e-05	0.000139	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—RHOA—asthma	1.86e-05	0.000198	CbGpPWpGaD
Maraviroc—Skin disorder—Prednisone—asthma	1.85e-05	0.000138	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—NOS3—asthma	1.84e-05	0.000196	CbGpPWpGaD
Maraviroc—Asthenia—Hydrocortisone—asthma	1.84e-05	0.000137	CcSEcCtD
Maraviroc—Anorexia—Prednisone—asthma	1.82e-05	0.000135	CcSEcCtD
Maraviroc—Pruritus—Hydrocortisone—asthma	1.81e-05	0.000135	CcSEcCtD
Maraviroc—Gastrointestinal pain—Dexamethasone—asthma	1.79e-05	0.000133	CcSEcCtD
Maraviroc—Gastrointestinal pain—Betamethasone—asthma	1.79e-05	0.000133	CcSEcCtD
Maraviroc—Hypersensitivity—Triamcinolone—asthma	1.78e-05	0.000132	CcSEcCtD
Maraviroc—Hypersensitivity—Methylprednisolone—asthma	1.77e-05	0.000132	CcSEcCtD
Maraviroc—Diarrhoea—Hydrocortisone—asthma	1.75e-05	0.00013	CcSEcCtD
Maraviroc—CCR5—Disease—TGFB1—asthma	1.74e-05	0.000185	CbGpPWpGaD
Maraviroc—Musculoskeletal discomfort—Prednisone—asthma	1.74e-05	0.000129	CcSEcCtD
Maraviroc—Dizziness—Prednisolone—asthma	1.74e-05	0.000129	CcSEcCtD
Maraviroc—Asthenia—Triamcinolone—asthma	1.73e-05	0.000129	CcSEcCtD
Maraviroc—Abdominal pain—Betamethasone—asthma	1.73e-05	0.000129	CcSEcCtD
Maraviroc—Body temperature increased—Dexamethasone—asthma	1.73e-05	0.000129	CcSEcCtD
Maraviroc—Body temperature increased—Betamethasone—asthma	1.73e-05	0.000129	CcSEcCtD
Maraviroc—Abdominal pain—Dexamethasone—asthma	1.73e-05	0.000129	CcSEcCtD
Maraviroc—Asthenia—Methylprednisolone—asthma	1.73e-05	0.000129	CcSEcCtD
Maraviroc—Insomnia—Prednisone—asthma	1.73e-05	0.000128	CcSEcCtD
Maraviroc—Paraesthesia—Prednisone—asthma	1.71e-05	0.000127	CcSEcCtD
Maraviroc—Pruritus—Triamcinolone—asthma	1.71e-05	0.000127	CcSEcCtD
Maraviroc—CCR5—Disease—EGFR—asthma	1.7e-05	0.000181	CbGpPWpGaD
Maraviroc—Pruritus—Methylprednisolone—asthma	1.7e-05	0.000127	CcSEcCtD
Maraviroc—Dizziness—Hydrocortisone—asthma	1.7e-05	0.000126	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—GSTP1—asthma	1.69e-05	0.00018	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—GSTP1—asthma	1.67e-05	0.000178	CbGpPWpGaD
Maraviroc—Decreased appetite—Prednisone—asthma	1.66e-05	0.000123	CcSEcCtD
Maraviroc—Rash—Prednisolone—asthma	1.65e-05	0.000123	CcSEcCtD
Maraviroc—Dermatitis—Prednisolone—asthma	1.65e-05	0.000123	CcSEcCtD
Maraviroc—Diarrhoea—Methylprednisolone—asthma	1.65e-05	0.000123	CcSEcCtD
Maraviroc—Fatigue—Prednisone—asthma	1.64e-05	0.000122	CcSEcCtD
Maraviroc—Headache—Prednisolone—asthma	1.64e-05	0.000122	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CXCL8—asthma	1.63e-05	0.000174	CbGpPWpGaD
Maraviroc—Constipation—Prednisone—asthma	1.63e-05	0.000121	CcSEcCtD
Maraviroc—Vomiting—Hydrocortisone—asthma	1.63e-05	0.000121	CcSEcCtD
Maraviroc—Rash—Hydrocortisone—asthma	1.62e-05	0.00012	CcSEcCtD
Maraviroc—Dermatitis—Hydrocortisone—asthma	1.61e-05	0.00012	CcSEcCtD
Maraviroc—Headache—Hydrocortisone—asthma	1.61e-05	0.000119	CcSEcCtD
Maraviroc—Dizziness—Triamcinolone—asthma	1.6e-05	0.000119	CcSEcCtD
Maraviroc—Dizziness—Methylprednisolone—asthma	1.59e-05	0.000118	CcSEcCtD
Maraviroc—Asthenia—Betamethasone—asthma	1.57e-05	0.000117	CcSEcCtD
Maraviroc—Asthenia—Dexamethasone—asthma	1.57e-05	0.000117	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—IL2—asthma	1.56e-05	0.000166	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Prednisone—asthma	1.56e-05	0.000116	CcSEcCtD
Maraviroc—Nausea—Prednisolone—asthma	1.56e-05	0.000116	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—GSTM1—asthma	1.56e-05	0.000166	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL6—asthma	1.55e-05	0.000165	CbGpPWpGaD
Maraviroc—Pruritus—Betamethasone—asthma	1.55e-05	0.000115	CcSEcCtD
Maraviroc—Pruritus—Dexamethasone—asthma	1.55e-05	0.000115	CcSEcCtD
Maraviroc—CYP3A4—Metapathway biotransformation—GSTM1—asthma	1.54e-05	0.000163	CbGpPWpGaD
Maraviroc—Vomiting—Triamcinolone—asthma	1.53e-05	0.000114	CcSEcCtD
Maraviroc—Vomiting—Methylprednisolone—asthma	1.53e-05	0.000114	CcSEcCtD
Maraviroc—Nausea—Hydrocortisone—asthma	1.52e-05	0.000113	CcSEcCtD
Maraviroc—Rash—Triamcinolone—asthma	1.52e-05	0.000113	CcSEcCtD
Maraviroc—Dermatitis—Triamcinolone—asthma	1.52e-05	0.000113	CcSEcCtD
Maraviroc—Rash—Methylprednisolone—asthma	1.52e-05	0.000113	CcSEcCtD
Maraviroc—Dermatitis—Methylprednisolone—asthma	1.52e-05	0.000113	CcSEcCtD
Maraviroc—Headache—Triamcinolone—asthma	1.51e-05	0.000112	CcSEcCtD
Maraviroc—Headache—Methylprednisolone—asthma	1.51e-05	0.000112	CcSEcCtD
Maraviroc—Abdominal pain—Prednisone—asthma	1.51e-05	0.000112	CcSEcCtD
Maraviroc—Body temperature increased—Prednisone—asthma	1.51e-05	0.000112	CcSEcCtD
Maraviroc—Diarrhoea—Dexamethasone—asthma	1.5e-05	0.000111	CcSEcCtD
Maraviroc—Diarrhoea—Betamethasone—asthma	1.5e-05	0.000111	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—MMP9—asthma	1.48e-05	0.000157	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PTEN—asthma	1.47e-05	0.000156	CbGpPWpGaD
Maraviroc—Dizziness—Betamethasone—asthma	1.45e-05	0.000108	CcSEcCtD
Maraviroc—Dizziness—Dexamethasone—asthma	1.45e-05	0.000108	CcSEcCtD
Maraviroc—Nausea—Triamcinolone—asthma	1.43e-05	0.000107	CcSEcCtD
Maraviroc—Nausea—Methylprednisolone—asthma	1.43e-05	0.000106	CcSEcCtD
Maraviroc—Hypersensitivity—Prednisone—asthma	1.41e-05	0.000105	CcSEcCtD
Maraviroc—Vomiting—Betamethasone—asthma	1.39e-05	0.000104	CcSEcCtD
Maraviroc—Vomiting—Dexamethasone—asthma	1.39e-05	0.000104	CcSEcCtD
Maraviroc—Rash—Betamethasone—asthma	1.38e-05	0.000103	CcSEcCtD
Maraviroc—Rash—Dexamethasone—asthma	1.38e-05	0.000103	CcSEcCtD
Maraviroc—Dermatitis—Betamethasone—asthma	1.38e-05	0.000103	CcSEcCtD
Maraviroc—Dermatitis—Dexamethasone—asthma	1.38e-05	0.000103	CcSEcCtD
Maraviroc—Headache—Betamethasone—asthma	1.37e-05	0.000102	CcSEcCtD
Maraviroc—Headache—Dexamethasone—asthma	1.37e-05	0.000102	CcSEcCtD
Maraviroc—Asthenia—Prednisone—asthma	1.37e-05	0.000102	CcSEcCtD
Maraviroc—Pruritus—Prednisone—asthma	1.35e-05	0.0001	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—VEGFA—asthma	1.33e-05	0.000141	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—STAT3—asthma	1.31e-05	0.00014	CbGpPWpGaD
Maraviroc—CCR5—Disease—IL6—asthma	1.31e-05	0.000139	CbGpPWpGaD
Maraviroc—Diarrhoea—Prednisone—asthma	1.3e-05	9.7e-05	CcSEcCtD
Maraviroc—Nausea—Dexamethasone—asthma	1.3e-05	9.67e-05	CcSEcCtD
Maraviroc—Nausea—Betamethasone—asthma	1.3e-05	9.67e-05	CcSEcCtD
Maraviroc—Dizziness—Prednisone—asthma	1.26e-05	9.38e-05	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—TGFB1—asthma	1.22e-05	0.00013	CbGpPWpGaD
Maraviroc—Vomiting—Prednisone—asthma	1.21e-05	9.02e-05	CcSEcCtD
Maraviroc—Rash—Prednisone—asthma	1.2e-05	8.94e-05	CcSEcCtD
Maraviroc—Dermatitis—Prednisone—asthma	1.2e-05	8.94e-05	CcSEcCtD
Maraviroc—Headache—Prednisone—asthma	1.19e-05	8.89e-05	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—EGFR—asthma	1.19e-05	0.000127	CbGpPWpGaD
Maraviroc—Nausea—Prednisone—asthma	1.13e-05	8.43e-05	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—POMC—asthma	1.1e-05	0.000117	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—LTC4S—asthma	1.04e-05	0.00011	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL6—asthma	9.17e-06	9.77e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—LTA4H—asthma	9e-06	9.58e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ARG1—asthma	7.86e-06	8.37e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALDH7A1—asthma	7.11e-06	7.57e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ARG2—asthma	6.82e-06	7.26e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALOX5AP—asthma	5.65e-06	6.02e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALOX15—asthma	5.65e-06	6.02e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CHAT—asthma	5.39e-06	5.74e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALOX5—asthma	4.8e-06	5.11e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CARM1—asthma	4.58e-06	4.88e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—DCN—asthma	4.52e-06	4.81e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALDH2—asthma	4.39e-06	4.68e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTT1—asthma	4.18e-06	4.45e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NQO1—asthma	3.47e-06	3.7e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ADCY2—asthma	3.4e-06	3.62e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTP1—asthma	2.9e-06	3.08e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HMOX1—asthma	2.86e-06	3.04e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ITPR1—asthma	2.85e-06	3.03e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CAT—asthma	2.82e-06	3e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PLA2G4A—asthma	2.66e-06	2.83e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTM1—asthma	2.66e-06	2.83e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPP2CA—asthma	2.45e-06	2.61e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—POMC—asthma	1.88e-06	2e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALB—asthma	1.72e-06	1.83e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NOS3—asthma	1.64e-06	1.75e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PTGS2—asthma	1.5e-06	1.6e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PTEN—asthma	1.31e-06	1.39e-05	CbGpPWpGaD
